Malaria in Early Life Study
NCT02001428
·
clinicaltrials.gov ↗
NA
Phase
COMPLETED
Status
757
Enrollment
OTHER
Sponsor class
Conditions
Plasmodium Falciparum Malaria
Plasmodium Vivax Malaria
Interventions
DRUG:
dihydroartemisinin-piperaquine
Sponsor
Gadjah Mada University
Collaborators
[object Object]
[object Object]
[object Object]